Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

High levels of AAV vector integration into CRISPR-induced DNA breaks

Open access

Abstract

Adeno-associated virus (AAV) vectors have shown promising results in preclinical models, but the genomic consequences of transduction with AAV vectors encoding CRISPR-Cas nucleases is still being examined. In this study, we observe high levels of AAV integration (up to 47%) into Cas9-induced double-strand breaks (DSBs) in therapeutically relevant genes in cultured murine neurons, mouse brain, muscle and cochlea. Genome-wide AAV mapping in mouse brain shows no overall increase of AAV integration except at the CRISPR/Cas9 target site. To allow detailed characterization of integration events we engineer a miniature AAV encoding a 465 bp lambda bacteriophage DNA (AAV-λ465), enabling sequencing of the entire integrated vector genome. The integration profile of AAV-465λ in cultured cells display both full-length and fragmented AAV genomes at Cas9 on-target sites. Our data indicate that AAV integration should be recognized as a common outcome for applications that utilize AAV for genome editing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-12449-2

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 AAV vectors integrate into CRISPR/Cas9 cut sites in vitro and in vivo. a Primary murine cortical neurons were transduced with an AAV1 vector encoding Cas9 as well as another AAV1 vector encoding a guide RNA (gRNA) against the genes indicated. Two different doses, 1e5 gc/cell (left panel) and 1e6 gc/cell (right panel), were tested. The negative control was neurons transduced by AAV-Cas9 vector without gRNA (Tmc1 gene was amplified by PCR for 1e5 gc/cell and APP gene was amplified for 1e6 gc/cell). Frequency of AAV sequences present at indels at the target site are shown in red vs total number of indels in blue. AAV capture efficiencies are shown as percentages on the graphs. Two biological replicates were sequenced for each condition (3 for APPSW gene, 1e6 gc/cell dose). b AAV integration into Cas9 cut sites targeting therapeutic genes in the murine hippocampus, cochlea or muscle. For APPSW, non-injected cerebellum or cortex was used as control. For Tmc1, non-injected cochleas were used. Animal numbers and the number of sequencing reactions are as follows (numbers of animals pooled per reaction included in parentheses): Hippocampus, control: n = 3 (3 reactions), Mecp2: n = 5 (2 reactions, n = 3 and 2), Dnmt3b: n = 5 (2 reactions, n = 3 and 2), APPSW: n = 7 (7 reactions). Cochlea samples, non-injected: n = 21 (2 reactions, n = 9 and 12), injected: n = 33 (4 reactions, n = 6, 6, 9, and 12 animals). Muscle samples: n = 8 (2 reactions, n = 4 and 4). c CRISPResso analysis showing small indels at cut site from hippocampus, injected with AAV-Cas9 and AAV-gRNA against Dnmt3b. d Bimodal distribution of indel sizes, the larger indicating AAV sequence integration at the cut site, with specific examples shown in e (two sequencing reactions from 2 and 3 animals, respectively). f Characterization of AAV vector region present in indels with AAV-Mecp2-Cas9 (left panel) and AAV-U6-gRNA-syn-GFP (right panel) in brain samples (Dnmt3b was targeted). g Distribution of AAV integration surrounding the CRISPR cut site in the case of hippocampus, Dnmt3b was targeted (two sequencing reactions from 2 and 3 animals, respectively). Bars represent mean ± SD. Source data are provided as a Source Data file
Fig. 1 AAV vectors integrate into CRISPR/Cas9 cut sites in vitro and in vivo. a Primary murine cortical neurons were transduced with an AAV1 vector encoding Cas9 as well as another AAV1 vector encoding a guide RNA (gRNA) against the genes indicated. Two different doses, 1e5 gc/cell (left panel) and 1e6 gc/cell (right panel), were tested. The negative control was neurons transduced by AAV-Cas9 vector without gRNA (Tmc1 gene was amplified by PCR for 1e5 gc/cell and APP gene was amplified for 1e6 gc/cell). Frequency of AAV sequences present at indels at the target site are shown in red vs total number of indels in blue. AAV capture efficiencies are shown as percentages on the graphs. Two biological replicates were sequenced for each condition (3 for APPSW gene, 1e6 gc/cell dose). b AAV integration into Cas9 cut sites targeting therapeutic genes in the murine hippocampus, cochlea or muscle. For APPSW, non-injected cerebellum or cortex was used as control. For Tmc1, non-injected cochleas were used. Animal numbers and the number of sequencing reactions are as follows (numbers of animals pooled per reaction included in parentheses): Hippocampus, control: n = 3 (3 reactions), Mecp2: n = 5 (2 reactions, n = 3 and 2), Dnmt3b: n = 5 (2 reactions, n = 3 and 2), APPSW: n = 7 (7 reactions). Cochlea samples, non-injected: n = 21 (2 reactions, n = 9 and 12), injected: n = 33 (4 reactions, n = 6, 6, 9, and 12 animals). Muscle samples: n = 8 (2 reactions, n = 4 and 4). c CRISPResso analysis showing small indels at cut site from hippocampus, injected with AAV-Cas9 and AAV-gRNA against Dnmt3b. d Bimodal distribution of indel sizes, the larger indicating AAV sequence integration at the cut site, with specific examples shown in e (two sequencing reactions from 2 and 3 animals, respectively). f Characterization of AAV vector region present in indels with AAV-Mecp2-Cas9 (left panel) and AAV-U6-gRNA-syn-GFP (right panel) in brain samples (Dnmt3b was targeted). g Distribution of AAV integration surrounding the CRISPR cut site in the case of hippocampus, Dnmt3b was targeted (two sequencing reactions from 2 and 3 animals, respectively). Bars represent mean ± SD. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 2 Genome-wide AAV mapping from CRISPR treated mouse brains. a Total number of unique integration sites. In the case of AAV-Cas9, AAV-gRNAMecp2, AAV-Cas9 + gRNAMecp2, and AAV-Cas9 + gRNADnmt3b, three mouse brains were pooled together for library construction. For AAV-Cas9 + gRNAAPPSW, hippocampus tissues from two animals were separately processed for library construction. The colors represent different genomic integration types and are based on the output of Virus-Clip. b Total number of reads that contain integrants normalized to total reads, based on the output from Virus-Clip. c Circos plots on showing the chromosomal location of AAV integration events. The more eccentric a dot is, the higher the normalized read count for that site is, on a logarithmic scale. The gene names inside the circle represent either CRISPR targets or sites that are common integration events (present at least in three different samples). Colors of gene names are the same as in b. The human APP gene was added as a separate chromosome. d Bubble-plots showing all integration sites. The size of the circle is proportional to the normalized read count. The color was kept consistent in the figure in respect to type of integration. Intergenic integrations are marked by the chromosome and location. Source data are provided as a Source Data file
Fig. 2 Genome-wide AAV mapping from CRISPR treated mouse brains. a Total number of unique integration sites. In the case of AAV-Cas9, AAV-gRNAMecp2, AAV-Cas9 + gRNAMecp2, and AAV-Cas9 + gRNADnmt3b, three mouse brains were pooled together for library construction. For AAV-Cas9 + gRNAAPPSW, hippocampus tissues from two animals were separately processed for library construction. The colors represent different genomic integration types and are based on the output of Virus-Clip. b Total number of reads that contain integrants normalized to total reads, based on the output from Virus-Clip. c Circos plots on showing the chromosomal location of AAV integration events. The more eccentric a dot is, the higher the normalized read count for that site is, on a logarithmic scale. The gene names inside the circle represent either CRISPR targets or sites that are common integration events (present at least in three different samples). Colors of gene names are the same as in b. The human APP gene was added as a separate chromosome. d Bubble-plots showing all integration sites. The size of the circle is proportional to the normalized read count. The color was kept consistent in the figure in respect to type of integration. Intergenic integrations are marked by the chromosome and location. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 3 Characterization of AAV vector integration into CRISPR cut sites using a miniaturized AAV genome. a Schematic of standard-sized AAV-CBA-FLuc vector (top, 4062 bases) vs miniaturized AAV-λ465 (bottom, 465 bases). Chart is to scale. b Transmission electron microscopic examination of iodixanol gradient-purified capsids of AAV2-λ or AAV2-CBA-FLuc. c quantitation of full vs empty capsids (bars represent mean ± SEM, data from two independent experiments, 15 and 10 images were taken and 954 and 1231 capsids were counted for AAV-λ465 and AAV-CBA-FLuc, respectively, and p = 0.0254, unpaired t-test). d Alkaline gel electrophoreses and Southern blot for AAV genomes from iodixanol purified vectors (AAV2-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::BsaI-sgRNA (pX601, 4.8 kb size) and AAV-λ465 (465 bp size) and cellular genomic DNA containing integrated AAV-λ465. For Southern blot, we used a probe specific for the ITR region. Star (*) highlights the 465 bp expected band and pound (#) sign highlights concatemers in the AAV-λ465 genome. e ITR-genomic fusion events quantified by integration-specific qPCR assay, using AAV-λ465 or AAV2-CBA-FLuc vectors determined (bars represent mean ± SD). Three independent experiments were performed using two technical replicates each. f Heatmap of AAV specific ITR nucleotide integration at CRISPR cut site. More saturated red indicates higher frequency of breaks at the given position. g Integration profile of the entire miniaturized AAV genome from U2-OS cells. h Representative individual AAV integration clones showing different forms of integration detected (for all the clones, see Supplementary Fig. 4). Source data are provided as a Source Data file
Fig. 3 Characterization of AAV vector integration into CRISPR cut sites using a miniaturized AAV genome. a Schematic of standard-sized AAV-CBA-FLuc vector (top, 4062 bases) vs miniaturized AAV-λ465 (bottom, 465 bases). Chart is to scale. b Transmission electron microscopic examination of iodixanol gradient-purified capsids of AAV2-λ or AAV2-CBA-FLuc. c quantitation of full vs empty capsids (bars represent mean ± SEM, data from two independent experiments, 15 and 10 images were taken and 954 and 1231 capsids were counted for AAV-λ465 and AAV-CBA-FLuc, respectively, and p = 0.0254, unpaired t-test). d Alkaline gel electrophoreses and Southern blot for AAV genomes from iodixanol purified vectors (AAV2-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::BsaI-sgRNA (pX601, 4.8 kb size) and AAV-λ465 (465 bp size) and cellular genomic DNA containing integrated AAV-λ465. For Southern blot, we used a probe specific for the ITR region. Star (*) highlights the 465 bp expected band and pound (#) sign highlights concatemers in the AAV-λ465 genome. e ITR-genomic fusion events quantified by integration-specific qPCR assay, using AAV-λ465 or AAV2-CBA-FLuc vectors determined (bars represent mean ± SD). Three independent experiments were performed using two technical replicates each. f Heatmap of AAV specific ITR nucleotide integration at CRISPR cut site. More saturated red indicates higher frequency of breaks at the given position. g Integration profile of the entire miniaturized AAV genome from U2-OS cells. h Representative individual AAV integration clones showing different forms of integration detected (for all the clones, see Supplementary Fig. 4). Source data are provided as a Source Data fileCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Miller, D. G., Petek, L. M. & Russell, D. W. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. https://doi.org/10.1038/ng1380 (2004). · DOI · Paper page

Cited by

See all 445

Metadata

Authors
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., Lööv, C., Ingelsson, M., Chamberlain, J. S., Corey, D. P., Aryee, M. J., Joung, J. K., Breakefield, X. O., Maguire, C. A., & György, B.
Affiliations
  • Harvard University (US)
  • Poznan University of Medical Sciences (PL)
  • Massachusetts General Hospital (US)
  • Institute of Molecular and Clinical Ophthalmology Basel (CH)
  • St. Jude Children's Research Hospital (US)
  • University of Washington (US)
  • Uppsala University (SE)
Corresponding author
  • Maguire, Casey A.
  • György, Bence
Venue
Nature Communications
Published
2019-09-30
Volume
10
Issue
1
Pages
4439-4439
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2976425815
Cited by
431
References
41
Citations by year
2026: 57 · 2025: 67 · 2024: 75 · 2023: 64 · 2022: 57 · 2021: 59 · 2020: 47 · 2019: 4
FWCI
25.16
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01DC017117)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus vectors, AAV integration, CRISPR/Cas9, DNA double-strand breaks, genome editing, mouse brain, muscle, cochlea
MeSH terms
Gene Editing, Dependovirus, Animals, Brain, Cell Line, Chromosome Mapping, Cochlea, Endonucleases, Genetic Vectors, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Muscles, Neurons, Bacteriophage lambda, Genetic Therapy, Virus Integration, Genome, Treatment Outcome, Gene Targeting, Mice, Targeted Gene Repair, DNA Breaks, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High levels of AAV vector integration into CRISPR-induced DNA breaks. https://app.cochat.ai/papers/10.1038/s41467-019-12449-2
The paper
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., Lööv, C., Ingelsson, M., Chamberlain, J. S., Corey, D. P., Aryee, M. J., Joung, J. K., Breakefield, X. O., Maguire, C. A., & György, B. (2019). High levels of AAV vector integration into CRISPR-induced DNA breaks. Nature Communications. https://doi.org/10.1038/s41467-019-12449-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.